GenoTher

📢 Our partner CentraleSupélec is recruiting! Our partner CentraleSupélec, engineering school within Paris-Saclay University, is seeking applications for a full Professor position in Bioengineering for Health. The successful candidate will contribute to both: 🔹 Education Development of a Bioengineering for Health specialization within the International Bachelor’s programme (Years 3 & 4) Creation of an international Health track within the general engineering curriculum 🔹 Research Bioproduction of high-value therapeutics within the LGPM Laboratory The position is open to both national and international candidates and is based on the Paris-Saclay campus (Gif-sur-Yvette, France). 📅 Application deadline: September 30, 2026 (12:00 noon, Paris time). For further information, please contact: 📧 François Puel – francois.puel@universite-paris-saclay.fr 📧 Ronan Vicquelin – ronan.vicquelin@centralesupelec.fr Don't hesitate to share this opportunity within your network! #Bioengineering #HealthInnovation #Bioproduction #ParisSaclay #CentraleSupélec #GenoTher

📣 GenoTher is launching its first Call for Expressions of Interest! Are you a startup or innovative SME developing breakthrough solutions in genetic medicine and advanced therapies? The GenoTher Genetic Medicine Incubation and Acceleration Program is looking for ambitious companies ready to accelerate their scientific, clinical and industrial development.   As part of the GenoTher Accelerator Program, selected companies will benefit from: 💶 Up to €300,000 of support to accelerate the development of their innovation  🔬 Personalised scientific and strategic support 🧬 Regulatory, CMC and industrialisation expertise 💡 Intellectual property and market access guidance 🤝 Connections with investors, industrial partners and CDMOs We welcome projects at Technology Readiness Level (TRL) 3 to TRL 7 in areas including: gene therapy, genome editing, cell therapy, therapeutic RNA, delivery technologies, biomanufacturing and CMC, AI, bioinformatics and digital biotechnology, technologies improving the efficacy and safety of genetic medicines. Applications from international companies are welcome, provided that part of their development strategy is linked to France, through R&D, industrial, clinical or business activities.   📅 Applications open: 17 July 2026 ⏳ Application deadline: 11 September 2026 🚀 Programme start: March 2027 Ready to accelerate the next generation of genetic medicines? 👉 Apply here: https://lnkd.in/e73NhwEY #GenoTher #GeneticMedicine #AdvancedTherapies #Startup #Innovation #France2030

📢 GenoTher is proud to be a Bronze Sponsor of the SITGeC 2026 Annual Meeting! We are delighted to support this year’s SITGeC Annual Meeting, bringing together the gene and cell therapy community to share the latest scientific and clinical advances. As part of the scientific program, Mario Amendola and Annarita Miccio will be speaking during the session “Gene Correction Strategies and Clinical Trials Updates.” Together with Anne Galy, they are leading GenoTher’s Genome Editing Platform, driving the development of innovative genome editing approaches to accelerate the translation of cutting-edge research into therapies for patients. If you’re attending the meeting, don’t miss this session and stop by to connect with us! Institut Imagine INSERM ART-TG Società Italiana di Terapia Genica e Cellulare(SITGEC) #SITGeC2026 #GenomeEditing #GeneticMedicine #Innovation #GenoTher

📣 Save the date: the Innovative and Combination Therapies Conference #5 will take place on Thursday, July 2, 2026, from 10:00 AM to 5:00 PM in Évry-Courcouronnes, France.   Organised by Genopole, Université Évry Paris-Saclay, and the Laboratoire de Biologie de l'Exercice pour la Performance et la Santé (LBEPS), this year’s edition will focus on therapeutic innovation and combination approaches for neuromuscular diseases.   As part of the agenda, Maria Grazia BIFERI, CSO of GenoTher, will present: Accelerating Genetic Medicine Through Integrated Ecosystems   The programme will cover: • Neurodegenerative diseases • Neuropathies and neuromuscular junction disorders • Myopathies • A roundtable on the potential and implementation of combination therapies   The event will bring together researchers, clinicians, and biotech companies to discuss advances in pre-clinical and clinical research.   Registration is free but required: https://lnkd.in/eKMjXBvY   See you there!   #Biotech #TherapeuticInnovation #GeneticMedicine #NeuromuscularDiseases #Healthcare #Research #Genopole

That’s a wrap for BIO International Convention 2026 in San Diego!

GenoTher was proud to take part in this major global gathering for the life sciences and biotechnology community. BIO was a valuable opportunity to introduce GenoTher internationally and share our ambition to build a connected French and European ecosystem for next-generation genetic medicines.

Over the week, we had many inspiring discussions with biotech companies, technology and manufacturing partners, research organisations, and innovation ecosystems from around the world.

It was also a pleasure to attend alongside our ecosystem colleagues from Genopole and WhiteLab Genomics, whose expertise in biotech innovation and AI is central to the development of the GenoTher ecosystem.

A warm thank you to Business France and Choose Paris Region for the opportunity to be part of the French Pavilion and to connect with so many inspiring international partners.

We are looking forward to continuing these conversations and turning the first connections made at BIO into meaningful collaborations.
 Agence de l'innovation en santé - Atlanpole Biotherapies - Boost Campus - CCI International Grand Est - Choose Paris Region - Eurobiomed - France Biotech - France Deeptech - French Healthcare - SOUTHERN CALIFORNIA - SD | French American Chamber of Commerce - Genopole - La French Tech San Diego - Lyonbiopôle Auvergne-Rhône-Alpes - MabDesign - WhiteLab Genomics 
#BIO2026 #GenoTher #GeneticMedicine #Biotech #Innovation #Ecosystem #France #BusinessFrance

📌 Save the date — 20 years of DIM! Join the Région Ile de France on Monday, June 29 for an afternoon celebrating two decades of support for research and innovation through the DIM programme. 📍 Île-de-France Regional Council Headquarters, Saint-Ouen-sur-Seine 🕜 1:30–7:30 PM Programme highlights include: • Round tables on the evolution and impact of the DIM programme • A poster session and visit of the DIM village • A keynote by Alain Aspect, Nobel Prize in Physics 2022 • A discussion with Valérie Pécresse and Philippe Gillet • Networking cocktail A great opportunity to connect with the research and innovation community in Île-de-France. 👉 Registration: https://lnkd.in/enmeXU7B #Research #Innovation #DIM #IledeFrance #Science Romain Vidal

[GENOTHER SUMMIT] That’s a wrap for the GenoTher Summit 2026! Over two days dedicated to Accelerating the Future of Genetic Medicine, we had the privilege of welcoming 400+ experts and 40+ international speakers across science, biotech, pharma, clinical development, manufacturing, regulation and investment. From the powerful story of a father fighting to save his child to next-generation technologies pushing science further, one message stood out: the challenge is not only to advance science, but to turn innovation into real impact for patients. Not just an event, the Summit reflects a broader ambition: positioning France and Europe as key drivers in the global race for next-generation therapies. As Marco Pintore, CEO of GenoTher, highlighted in his closing remarks: “Together, we explored key questions shaping the future of genetic medicine. What comes through clearly is the strength of this community, and the importance of working together to turn scientific progress into real impact for patients.” A warm thank you to all speakers, chairs, moderators, panelists, sponsors, partners and participants for making this second edition such a success. 👉 Stay tuned in the coming days for speaker interviews, photos and video highlights capturing the best moments of this amazing event. #GenoTherSummit #GenoTherSummit2026 #GeneticMedicine #GeneTherapy #AdvancedTherapies #Biotech #Bioproduction #AI #TherapeuticInnovation Frederic Revah Marco Pintore Judit Nagy Maria Grazia BIFERI Sophie SETIAO 🧭 Mélodie Dupré Marina Cavazzana Daniel Bauer Nicolas Levy Juliette Hordeaux Terry Pirovolakis Yann Echelard Pauline Lestringant Gavin Yirajen VUDDAMALAY, PhD Christian Mueller Federico Mingozzi Bill Peranteau Gabriele Lignani, PhD FRSB Jayanth Chandran Liz Ramsburg Adrian Veres Jack Byrne, PhD Paolo Morgese David Del Bourgo Philippe Moingeon Jonathan (John) Finn Félix Raimundo, PhD Claude Bertrand Frédéric Parmentier Michaela Semeraro Lucas Elle Paul Baduel Julien Cottineau Emmanuelle Cameau Louis Marie de Montgrand © Jean-Yves Seguy / AFM-Téléthon

Kicking off Day 2 of the GenoTher Summit 2026 in Paris! 🚀 Today’s programme is dedicated to artificial intelligence as a catalyst for therapeutic innovation, exploring how AI is reshaping the future of genetic medicine — from therapeutic design and patient access to bioproduction, modeling and digital twins. We are opening the day with a keynote by Philippe Moingeon on AI-designed drug discoveries and their potential for genetic medicine. Looking forward to another inspiring day of scientific exchange and collaboration in Paris. #GenoTherSummit2026 #ArtificialIntelligence #GeneticMedicine #GeneTherapy GenoTher David Del Bourgo Jonathan (John) Finn Jean Lachowicz Félix Raimundo, PhD Claude Bertrand Frédéric Parmentier Michaela Semeraro Lucas Elle Edouard Nicoud Louis Marie de Montgrand Emmanuelle Cameau Paul Baduel Julien Cottineau

We are live! 🚀 The GenoTher Summit 2026 has officially started at Maison de l’Océan in Paris. Over the next day and a half, we are bringing together international experts, innovators and key players in genetic medicine to discuss the future of the field — from advanced therapies and delivery technologies to bioproduction, AI and ecosystem collaboration. Thank you to all our speakers, sponsors, partners and participants for joining us. Let’s accelerate the future of genetic medicine together. #GenoTherSummit2026 #GeneticMedicine #GeneTherapy #AdvancedTherapies

Meet Ypso-Facto at the GenoTher Summit 2026, Maison de l'Océan, Paris! On June 18, Edouard Nicoud, Co-CEO of Ypso-Facto, will join the panel discussion: “Engineering Bioproduction with AI, Modelling and Digital Twins” Alongside experts from Sanofi Vaccines, Whitelab Genomics, Cytiva, and Yposkesi, the panel will explore how AI, predictive modelling, and digital twins are transforming CMC, process optimization, and large-scale bioproduction. See you there! #AI #DigitalTwin #Bioprocess #Biomanufacturing #GeneTherapy #YpsoFacto #GenoTherSummit